Clinical Trials
2 trialsNCT00450619 2017-01-04
153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00316940 2013-09-20
Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
National Cancer Institute (NCI)
Phase 1 Completed